The gut microbiota is involved in the regulation of cognition, mood, anxiety, and pain, and can impact cognitive functions by producing neuroactive substances or releasing bacterial by-products and metabolites. No information is available on the effects of a probiotic supplementation on brain function of HIV+ subjects. In light of the above considerations, we performed a pilot study in cART-treated HIV-1-positive patients with long-term virologic suppression. The aims were to analyze the effect of high-concentration multistrain probiotic supplementation (Vivomixx®; Visbiome®) on several neurocognitive abilities and to evaluate the safety of this supplementation.

A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients / Ceccarelli, G., Fratino, M., Selvaggi, C., Giustini, N., Serafino, S., Schietroma, I., Corano Scheri, G., Pavone, P., Passavanti, G., Alunni Fegatelli, D., Mezzaroma, I., Antonelli, G., Vullo, V., Scagnolari, C., D'Ettorre, G.. - In: BRAIN AND BEHAVIOR. - ISSN 2162-3279. - ELETTRONICO. - 7:8(2017), p. e00756. [10.1002/brb3.756]

A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients

Ceccarelli, Giancarlo;Fratino, Mariangela;Selvaggi, Carla;Giustini, Noemi;Serafino, Sara;Corano Scheri, Giuseppe;Pavone, Paolo;Alunni Fegatelli, Danilo;Mezzaroma, Ivano;Antonelli, Guido;Vullo, Vincenzo;Scagnolari, Carolina;D'ettorre, Gabriella
2017

Abstract

The gut microbiota is involved in the regulation of cognition, mood, anxiety, and pain, and can impact cognitive functions by producing neuroactive substances or releasing bacterial by-products and metabolites. No information is available on the effects of a probiotic supplementation on brain function of HIV+ subjects. In light of the above considerations, we performed a pilot study in cART-treated HIV-1-positive patients with long-term virologic suppression. The aims were to analyze the effect of high-concentration multistrain probiotic supplementation (Vivomixx®; Visbiome®) on several neurocognitive abilities and to evaluate the safety of this supplementation.
2017
HIV; miRNA; miRNA‐29; neuropsychological performance; probiotics
01 Pubblicazione su rivista::01a Articolo in rivista
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients / Ceccarelli, G., Fratino, M., Selvaggi, C., Giustini, N., Serafino, S., Schietroma, I., Corano Scheri, G., Pavone, P., Passavanti, G., Alunni Fegatelli, D., Mezzaroma, I., Antonelli, G., Vullo, V., Scagnolari, C., D'Ettorre, G.. - In: BRAIN AND BEHAVIOR. - ISSN 2162-3279. - ELETTRONICO. - 7:8(2017), p. e00756. [10.1002/brb3.756]
File allegati a questo prodotto
File Dimensione Formato  
Ceccarelli_pilot-study_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 406.38 kB
Formato Adobe PDF
406.38 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1021818
Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 50
social impact